Pharma Focus America
ThermoFisherScientific - Custom and Bulks

Projects

The pharmaceutical projects listed in this phase are those that receive periodic global announcements.

€80 Million Investment by GEA to Enhance Pharmaceutical Standards at Elsdorf Factory

GEA has announced a substantial investment of 80 million to enhance pharmaceutical production standards at its Elsdorf factory, aiming to modernize facilities and improve operational efficiency

Abzena Invests $5 Million to Expand Bioconjugation and ADC Capabilities

Abzena, a leading CDMO for complex biologics and bioconjugates, announced a significant expansion of its Bristol, PA site for bioconjugate development and cGMP manufacturing

Sandoz Breaks Ground on New Antibiotic Production Facility in Austria with EUR 50 Million Investment

Sandoz, a global leader in generic and biosimilar medicines, opens new production facility in Kundl, Austria Facility aims to provide affordable lifesaving drugs solely manufactured in Europe,

AbbVie Invests $223 Million to Enhance Biologics Manufacturing Capacity at Singapore Site

AbbVie commenced the construction of a new expansion at its Singapore manufacturing facility, emphasizing its commitment

AGC Biologics to Break Ground on New 50 Billion Yen Manufacturing Site in Yokohama, Japan

AGC Biologics is planning to build a new manufacturing facility at AGC Incs Yokohama Technical Center in Japan This expansion is part of AGC Biologics strategic growth strategy to enhance pharmaceutical development

Fujifilm Invest $200 Million to Advance Cell Therapy Development and Expand Manufacturing

FUJIFILM Cellular Dynamics, specializing in human induced pluripotent stem cells and iPSCderived cells, and FUJIFILM Diosynth Biotechnologies in California, a prominent CDMO in biologics and advanced therapies,

Eli Lilly Reveals Plans for a $2.5 Billion Investment to Expand Injectable Manufacturing Capacity in Germany

Eli Lilly and Company plans to build a hightech manufacturing facility in Alzey, Rhineland Palatinate, Germany

Aragen Unveils Groundbreaking $30 Million Investment for Bio-Manufacturing Facility in India

Aragen, a leading CRDMO specializing in small molecules and biologics, is establishing a new biologics manufacturing facility in Bangalore, India

Bayer Invests $250 Million in First Global Cell Therapy Manufacturing Facility for Regenerative Medicines

The facility aims to produce cell and gene therapies on a global scale, making them more accessible worldwide

Sandoz Invests $90 Million in Advanced Biosimilar Technical Development CenterIntroduction

Sandozs investment sets the stage for a significant transformation of the Ljubljana site into a central hub for advancing biosimilar products within the company

Thermo Fisher Scientific viral vector services (VVS)Future Labs Live USA 2024patheon - Mastering API production at every scaleWorld Vaccine Congress Europe 2024World Orphan Drug Congress 2024Advanced Therapies USA 2024World Orphan Drug Congress Europe 2024Healthcare CNO SummitHealthcare CMO Summit